Author:
Chong Tae W.,Balch Glen C.,Kehoe Siobhan M.,Margulis Vitaly,Saint-Cyr Michel
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Lu JY, Xiao Y, Qiu HZ, Wu B, Lin GL, Xu L, Zhang GN, Hu K. Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer. J Surg Oncol. 2013; 108:213–9.
2. Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13:1152–60.
3. Wiatrek RL, Thomas JS, Papaconstantinou HT. Perineal wound complications after abdominoperineal resection. Clin Colon Rectal Surg. 2008;21:76–85.
4. Luna-Pérez P, Rodríguez-Ramírez S, Vega J, Sandoval E, Labastida S. Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma. Rev Invest Clin. 2001;53:388–95.
5. Farid H, O’Connell TX. Methods to decrease the morbidity of abdominoperineal resection. Am Surg. 1995;61:1061–4.